ANRO · Categories · Form 4

ANRO - SEC Form 4 insider transactions

Alto Neuroscience Inc. (ANRO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ANRO

• 17d
  SEC Form 4 filed by Director Miller Andrew Craig

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 31d
  PRESIDENT AND CEO Etkin Amit gifted 400,000 shares, decreasing direct ownership by 32% to 833,949 units (SEC Form 4)

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 32d
  SEC Form 4 filed by Director Sanchez Ramiro

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 32d
  SEC Form 4 filed by Director Cox Christopher Nixon

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 32d
  SEC Form 4 filed by Director Manji Husseini

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 32d
  SEC Form 4 filed by Director Dreyfus Andrew

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 32d
  SEC Form 4 filed by Director York Gwill

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 104d
  PRESIDENT AND CEO Etkin Amit covered exercise/tax liability with 6,227 shares, decreasing direct ownership by 0.50% to 1,233,949 units (SEC Form 4)

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 104d
  CHIEF FINANCIAL OFFICER & CBO Smith Nicholas Conrad covered exercise/tax liability with 2,806 shares, decreasing direct ownership by 10% to 24,060 units (SEC Form 4)

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 122d
  SEC Form 4 filed by PRESIDENT AND CEO Etkin Amit

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 122d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Savitz Adam

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 122d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER & CBO Smith Nicholas Conrad

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 122d
  SEC Form 4 filed by CHIEF OPERATING OFFICER Hanley Jr. Michael Conick

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 160d
  SEC Form 4 filed by Director York Gwill

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 160d
  SEC Form 4 filed by Director Cox Christopher Nixon

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 160d
  SEC Form 4 filed by Director Manji Husseini

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 160d
  SEC Form 4 filed by Director Sanchez Ramiro

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 305d
  SEC Form 4 filed by Director Sanchez Ramiro

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 342d
  SEC Form 4 filed by CHIEF OPERATING OFFICER Hanley Jr. Michael Conick

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 342d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Savitz Adam

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 342d
  SEC Form 4 filed by PRESIDENT AND CEO Etkin Amit

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 342d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER & CBO Smith Nicholas Conrad

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 396d
  SEC Form 4 filed by Director Manji Husseini

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 396d
  SEC Form 4 filed by Director Cox Christopher Nixon

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 396d
  SEC Form 4 filed by Director York Gwill

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 396d
  SEC Form 4 filed by Director Dreyfus Andrew

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 493d
  SEC Form 4 filed by CHIEF OPERATING OFFICER Hanley Jr. Michael Conick

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 493d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER & CBO Smith Nicholas Conrad

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 493d
  SEC Form 4 filed by CHIEF MEDICAL OFFICER Savitz Adam

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 493d
  SEC Form 4 filed by PRESIDENT AND CEO Etkin Amit

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 525d
  SEC Form 4 filed by Director York Gwill

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 525d
  SEC Form 4 filed by Director Manji Husseini

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 525d
  SEC Form 4 filed by Director Cox Christopher Nixon

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 754d
  SEC Form 4 filed by Hanley Jr. Michael Conick

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 825d
  SEC Form 4 filed by Radhakrishnan Maha

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 831d
  Apeiron Investment Group Ltd. converted options into 926,539 shares (SEC Form 4)

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 832d
  SEC Form 4 filed by Savitz Adam

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 832d
  Smith Nicholas Conrad was granted 19,153 shares, increasing direct ownership by 1,225% to 20,716 units (SEC Form 4)

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)
• 832d
  Etkin Amit was granted 34,711 shares, increasing direct ownership by 3% to 1,240,176 units (SEC Form 4)

  4 - Alto Neuroscience, Inc. (0001999480) (Issuer)

Other ANRO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends